Atlas Trials

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Clinical trial NCT00866502 · COMPLETED

Trial details

NCT number
NCT00866502
Sponsor
Newron Sweden AB
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2009-03-01
Primary completion
2011-03-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.